Detalhe da pesquisa
1.
Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trial.
Am J Hematol
; 99(1): 57-67, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014779
2.
Early initiation of second-line therapy in primary immune thrombocytopenia: insights from real-world evidence.
Ann Hematol
; 102(8): 2051-2058, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300567
3.
Thrombopoietin receptor agonist discontinuation rates and reasons among patients with immune thrombocytopenia: a study of administrative claims linked with medical chart review.
Ann Hematol
; 101(9): 1915-1924, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35849155
4.
Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment.
Am J Hematol
; 96(2): 188-198, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33170956
5.
Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of life.
Am J Hematol
; 96(2): 199-207, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33107998
6.
Activity and safety of eltrombopag in combination with cyclosporin A as firstline treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study.
Lancet Haematol
; 11(3): e206-e215, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38335978
7.
Overuse of corticosteroids in patients with immune thrombocytopenia (ITP) between 2011 and 2017 in the United States.
EJHaem
; 4(2): 350-357, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37206283
8.
Chronic Myeloid Leukemia Patient's Voice About the Experience of Treatment-Free Remission Failure: Results From the Italian Sub-Study of ENESTPath Exploring the Emotional Experience of Patients During Different Phases of a Clinical Trial.
Front Psychol
; 10: 329, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30842749
9.
Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry).
J Cancer Res Clin Oncol
; 145(6): 1645-1650, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30941573
10.
Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase: ENEST1st subanalysis.
J Cancer Res Clin Oncol
; 143(8): 1585-1596, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28364360